Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality Home
BiotechReality – Information Intelligence System for Biopharma
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Clinical Data #FDA Approval #Cancer #Phase 3 Trials #Novo Nordisk

Editor's Desk

Biotechnology News Toxicology

CRISPR technology paves the way for a new antidote for Cobra bites

  • By Editor's Desk
  • 19 July 2024
Cobra Snake Image

Every year, hundreds of individuals are killed by cobra venom, and an estimated 100,000 more suffer severe injuries from necrosis, which is the loss of bodily tissue and cells and can result in amputation.

Tagged Cobra Venom, CRISPR
Healthcare & Pharmaceuticals News Research

New antibody therapy to neutralize a wide variety of HIV-1 strains

  • By Editor's Desk
  • 19 July 2024
hiv antibody therapy

This new study offers a broadly useful technique to improve nanobodies’ performance. Artificially created antibody fragments, known as nanobodies, are around 10 times smaller than regular antibodies.

Tagged Antibody Therapy, HIV
Gene Therapy News Research

Researchers discovered a new Gene Therapy for muscular dystrophy

  • By Editor's Desk
  • 18 July 2024
gene editing tool

The protein dystrophin, absent in people with muscular dystrophy, will subsequently begin to be produced by the additional genetic code.

Tagged Gene Therapy, Muscular Dystrophy
Machine Learning News

New subtypes of Parkinson’s Disease can be defined by Machine Learning

  • By Editor's Desk
  • 17 July 2024
anti amyloid clinical trial alzheimer's drug

The different patterns of illness development that the subtypes exhibited allowed the investigators to identify them.

Tagged Machine Learning, Parkinson's disease
Research News

Research: A new neural biomarker for OCD

  • By Editor's Desk
  • 14 July 2024
alzheimer's treatments and therapies

Two to three per cent of people worldwide suffer from OCD, a prevalent and debilitating mental illness. OCD affects over two million people in the United States.

Tagged Neural Biomarker, OCD
Disease Biology

E. faecalis biofilms are targeted by a phage-derived enzyme to reduce acute Graft-Versus-Host Disease

  • By Editor's Desk
  • 12 July 2024
phage biofilm

Recently, Japanese researchers discovered endolysin, an enzyme generated from bacteriophages that may attack Enterococcus faecalis biofilms. Their results provide promise for customized allo-HCT therapies.

Tagged Biofilms, Enzyme, Host Disease
Gene Therapy News Research

Cystic Fibrosis mutation in human lung cells corrected by Prime Editing

  • By Editor's Desk
  • 11 July 2024
cystic fibrosis in the lungs

Researchers at the University of Iowa, the Broad Institute of MIT, Harvard, and Harvard have now created a gene-editing method that effectively fixes the most prevalent mutation affecting 85% of patients

Tagged Cystic Fibrosis, Lungs
Cancer Research

New research suggests an improved method for the detection of thyroid cancer

  • By Editor's Desk
  • 8 July 2024
how to detect thyroid cancer

The study investigated if cancer status differed according to individuals’ RAS genetic variations.

Tagged Cancer, Thyroid Cancer
Immunology News

Discovery of new T cells and genes related to immune disorders

  • By Editor's Desk
  • 6 July 2024
detection of epilepsy

They discovered many subsets of uncommon T cell types, making up less than 5% of the total, after examining almost a million human T cells.

Tagged Genes, Immune Disorders, T cells
Clinical Trials Gene Therapy

In a young kid, gene therapy halts the advancement of a rare hereditary disease

  • By Editor's Desk
  • 4 July 2024
gene therapy in kids

Delivering a healthy copy of a gene to a person whose gene(s) are malfunctioning is known as gene therapy.

Tagged Gene Therapy

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biosimilars
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • CDMO
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRDMO
  • CRO
  • Cybersecurity
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Merger & Acquisitions
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan
Clinical Data Healthcare & Pharmaceuticals News Oncology

MSD Oncology Pipeline Advances With First Phase 3 Data for Intismeran Autogene Plus KEYTRUDA and Sacituzumab Tirumotecan

17 October 202617 October 2026
Editor's Desk
Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types
Regulatory Approval Healthcare & Pharmaceuticals News Oncology

Regeneron Libtayo Dosing Update: CHMP Recommends EU Approval of Every-Six-Week Cemiplimab Regimen Across All Cancer Types

16 October 202617 October 2026
Editor's Desk
Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year
Clinical Data Healthcare & Pharmaceuticals News

Lilly Omvoh (mirikizumab-mrkz) Delivers Comprehensive Disease Control in Ulcerative Colitis and Deep Remission in Crohn’s Disease at One Year

15 October 202615 October 2026
Editor's Desk
Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing
Business Clinical Data Gene Therapy Healthcare & Pharmaceuticals News

Charles River Magellan Collaboration Backs Zelestrocel Osteoarthritis Therapy With cGMP NGS Viral Safety Testing

14 October 202614 October 2026
Editor's Desk
Johnson & Johnson Q3 2026 Results: J&J Raises 2026 Guidance as OTTAVA, IMAAVY and RYBREVANT FASPRO Advance
Business Healthcare & Pharmaceuticals News

Johnson & Johnson Q3 2026 Results: J&J Raises 2026 Guidance as OTTAVA, IMAAVY and RYBREVANT FASPRO Advance

13 October 202614 October 2026
Editor's Desk
IQVIA Veeva Clinical Operations Expansion: IQVIA Selects Veeva CTMS, eTMF, Study Startup and Site Connect as Enterprise Standards
Business Artificial Intelligence Clinical Data Healthcare & Pharmaceuticals News Research

IQVIA Veeva Clinical Operations Expansion: IQVIA Selects Veeva CTMS, eTMF, Study Startup and Site Connect as Enterprise Standards

13 October 202613 October 2026
Editor's Desk
Advertisement
BiotechReality JobFinder

  • Clinical Project Management Director – IQVIA
    16 October 2026
  • Senior Manager, Global Digital Marketing – Lonza
    11 October 2026
  • Commercial Product Manager – Centrifuge – ThermoFisher, Singapore & Malaysia
    7 October 2026
  • Regulatory Affairs Specialist – Lonza, Hyderabad
    4 October 2026
  • Component Engineer – Cytiva, Bangalore
    29 September 2026

BiotechReality Shots Weekly Newsletter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter